Please sign in to follow a disease.
Peritoneal neoplasm
MONDO:0006901A benign or malignant neoplasm that affects the peritoneal cavity. Representative examples of benign neoplasms include adenomatoid tumor and disseminated peritoneal leiomyomatosis. Representative examples of malignant neoplasms include primary peritoneal carcinoma, metastatic carcinoma to the peritoneum, and malignant mesothelioma.
Also known as: neoplasm of peritoneum, peritoneal neoplasm, peritoneum neoplasm, peritoneum neoplasm (disease), peritoneum tumor, peritoneum tumour, tumor of peritoneum, tumour of peritoneum
1932 clinical trials for this condition and its sub-types, 64 tagged with Peritoneal neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Peritoneal neoplasm
-
Peritoneum cancer 67 trials · 513 incl. sub-types
6 sub-types
- Peritoneal carcinoma 16 trials · 389 incl. sub-types Sub-types →
- Peritoneal carcinomatosis 91 trials · 101 incl. sub-types Sub-types →
- Malignant peritoneal mesothelioma 13 trials
- Malignant peritoneal germ cell tumor 0 trials
- Malignant peritoneal solitary fibrous tumor 0 trials
- Round ligament malignant neoplasm 0 trials
-
Peritoneal mesothelioma 14 trials · 22 incl. sub-types
5 sub-types
- Malignant peritoneal mesothelioma 13 trials
- Benign peritoneal mesothelioma 0 trials
- Peritoneal mesothelioma in situ 0 trials
- Peritoneal multicystic mesothelioma 0 trials
- Peritoneal well differentiated papillary mesothelioma 0 trials
-
Peritoneal benign neoplasm 0 trials
3 sub-types
- Benign peritoneal mesothelioma 0 trials
- Benign peritoneal solitary fibrous tumor 0 trials
- Disseminated peritoneal leiomyomatosis 0 trials
-
Peritoneal solitary fibrous tumor 0 trials
1 sub-type
Most studied deeper sub-types
-
New chemo combo for stomach cancer shows promise in early trial
Disease control Stopped earlyThis study tested a combination of chemotherapy drugs for people with stomach cancer that has spread inside the belly. The treatment involved giving one drug directly into the abdomen and through a vein, plus a second drug taken by mouth. The goal was to see if this approach coul…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Microscopic drug particles target Hard-to-Treat abdominal cancers in early trial
Disease control Stopped earlyThis early-phase trial tested a new way to deliver chemotherapy directly into the abdomen for people with advanced cancers that have spread to the lining of the belly. The treatment uses tiny particles loaded with paclitaxel, a standard chemo drug, to better target tumors. Only 4…
Phase 1 • Sponsor: Carlos Chan • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cancer drug trial halted early – what we know
Disease control Stopped earlyThis study tested a new drug, felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors like ovarian, breast, and lung cancer. The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC